Tsutomu Numata1, Kiyoshi Hiruma, Tomoko Tsukuda
1Dept. of Otorhinolarygology, Chiba National Hospital, 4-1-2 Tsubakimori, Chuo-ku, Chiba 260-8606, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Malignant mixed tumors, often carcinoma in pleomorphic adenoma, represent about 10% of salivary gland carcinomas. Treatment involves surgical excision, with radiation therapy for advanced cases, and survival rates around 55% and 43% at 5 and 10 years.
Area of Science:
Context:
Purpose:
Summary:
Impact: